1. Home
  2. SLDB vs TLS Comparison

SLDB vs TLS Comparison

Compare SLDB & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLDB
  • TLS
  • Stock Information
  • Founded
  • SLDB 2013
  • TLS 1969
  • Country
  • SLDB United States
  • TLS United States
  • Employees
  • SLDB N/A
  • TLS N/A
  • Industry
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • TLS EDP Services
  • Sector
  • SLDB Health Care
  • TLS Technology
  • Exchange
  • SLDB Nasdaq
  • TLS Nasdaq
  • Market Cap
  • SLDB 433.0M
  • TLS 403.5M
  • IPO Year
  • SLDB 2018
  • TLS 2020
  • Fundamental
  • Price
  • SLDB $5.13
  • TLS $6.33
  • Analyst Decision
  • SLDB Strong Buy
  • TLS Buy
  • Analyst Count
  • SLDB 10
  • TLS 5
  • Target Price
  • SLDB $15.00
  • TLS $4.88
  • AVG Volume (30 Days)
  • SLDB 872.0K
  • TLS 3.1M
  • Earning Date
  • SLDB 11-05-2025
  • TLS 08-11-2025
  • Dividend Yield
  • SLDB N/A
  • TLS N/A
  • EPS Growth
  • SLDB N/A
  • TLS N/A
  • EPS
  • SLDB N/A
  • TLS N/A
  • Revenue
  • SLDB N/A
  • TLS $116,739,000.00
  • Revenue This Year
  • SLDB N/A
  • TLS $47.80
  • Revenue Next Year
  • SLDB N/A
  • TLS $26.19
  • P/E Ratio
  • SLDB N/A
  • TLS N/A
  • Revenue Growth
  • SLDB N/A
  • TLS N/A
  • 52 Week Low
  • SLDB $2.41
  • TLS $1.83
  • 52 Week High
  • SLDB $8.45
  • TLS $6.90
  • Technical
  • Relative Strength Index (RSI)
  • SLDB 36.32
  • TLS 68.23
  • Support Level
  • SLDB $5.34
  • TLS $6.04
  • Resistance Level
  • SLDB $5.77
  • TLS $6.90
  • Average True Range (ATR)
  • SLDB 0.32
  • TLS 0.43
  • MACD
  • SLDB -0.07
  • TLS -0.05
  • Stochastic Oscillator
  • SLDB 8.74
  • TLS 60.42

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

Share on Social Networks: